Nothing Special   »   [go: up one dir, main page]

IT7822019A0 - Composizione farmaceutica adattivita' antibroncospastica e antitosse. - Google Patents

Composizione farmaceutica adattivita' antibroncospastica e antitosse.

Info

Publication number
IT7822019A0
IT7822019A0 IT7822019A IT2201978A IT7822019A0 IT 7822019 A0 IT7822019 A0 IT 7822019A0 IT 7822019 A IT7822019 A IT 7822019A IT 2201978 A IT2201978 A IT 2201978A IT 7822019 A0 IT7822019 A0 IT 7822019A0
Authority
IT
Italy
Prior art keywords
anticough
antibronchospastic
suitability
pharmaceutical composition
pharmaceutical
Prior art date
Application number
IT7822019A
Other languages
English (en)
Other versions
IT1113122B (it
Inventor
Jose Franzone
Teresio Tamietto
Original Assignee
Abc Ist Biolog Chem Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abc Ist Biolog Chem Spa filed Critical Abc Ist Biolog Chem Spa
Priority to IT22019/78A priority Critical patent/IT1113122B/it
Publication of IT7822019A0 publication Critical patent/IT7822019A0/it
Priority to GB26079/78A priority patent/GB1582510A/en
Priority to DE2827497A priority patent/DE2827497C2/de
Priority to FR7818978A priority patent/FR2421614A1/fr
Priority to BE2057104A priority patent/BE868556A/xx
Priority to NL7807152A priority patent/NL7807152A/xx
Priority to US05/950,749 priority patent/US4187308A/en
Priority to JP442579A priority patent/JPS54138127A/ja
Application granted granted Critical
Publication of IT1113122B publication Critical patent/IT1113122B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT22019/78A 1978-04-06 1978-04-06 Composizione farmaceutica ad attivita' antibrocospastica e antitosse IT1113122B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT22019/78A IT1113122B (it) 1978-04-06 1978-04-06 Composizione farmaceutica ad attivita' antibrocospastica e antitosse
GB26079/78A GB1582510A (en) 1978-04-06 1978-05-31 Pharmaceutical composition with anti-bronchospasmodic and anti-tussive activity
DE2827497A DE2827497C2 (de) 1978-04-06 1978-06-22 Verwendung von 2-(7'-Theophyllinmethyl)-1,3-dioxolan zur Bekämpfung von bronchialen Erkrankungen
FR7818978A FR2421614A1 (fr) 1978-04-06 1978-06-26 Composition pharmaceutique a base de 2-(7'-theophyllinomethyl)-1,3-dioxolane
BE2057104A BE868556A (nl) 1978-04-06 1978-06-29 Farmaceutisch preparaat met werking tegen bronchospasmen en tegen hoest, werkwijze voor de behandeling van bronchospasmen, bronchiale astma, obstructieve chronische bronchitis en spasmodisch hoesten
NL7807152A NL7807152A (nl) 1978-04-06 1978-06-30 Farmaceutisch preparaat met werking tegen bronchospas- men en tegen hoest, werkwijze voor de behandeling van bronchospasmen, bronchiale astma, obstructieve chroni- sche bronchitus en spasmodisch hoesten.
US05/950,749 US4187308A (en) 1978-04-06 1978-10-12 Pharmaceutical composition with anti-bronchospasmodic and anti-tussive activity
JP442579A JPS54138127A (en) 1978-04-06 1979-01-16 Treating agent for bronchus convulsion or cough

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22019/78A IT1113122B (it) 1978-04-06 1978-04-06 Composizione farmaceutica ad attivita' antibrocospastica e antitosse

Publications (2)

Publication Number Publication Date
IT7822019A0 true IT7822019A0 (it) 1978-04-06
IT1113122B IT1113122B (it) 1986-01-20

Family

ID=11190276

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22019/78A IT1113122B (it) 1978-04-06 1978-04-06 Composizione farmaceutica ad attivita' antibrocospastica e antitosse

Country Status (8)

Country Link
US (1) US4187308A (it)
JP (1) JPS54138127A (it)
BE (1) BE868556A (it)
DE (1) DE2827497C2 (it)
FR (1) FR2421614A1 (it)
GB (1) GB1582510A (it)
IT (1) IT1113122B (it)
NL (1) NL7807152A (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59664A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
IT1195267B (it) * 1980-04-15 1988-10-12 Abc Ist Biolog Chem Spa Derivati teofillinmetildiossolanici,procedimento per la loro preparazione e relative composizioni farmaceutiche
FR2531337A1 (fr) * 1982-08-04 1984-02-10 Hoechst Lab Nouvelles formes galeniques administrables par voie orale, des derives de la dimethylxanthine solubles
IT1197516B (it) * 1986-12-24 1988-11-30 Abc Ist Biolog Chem Spa Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
HU198933B (en) * 1987-11-02 1989-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new xanthine derivatives and pharmaceutical compositions comprising same as active ingredient
CN1037604C (zh) * 1994-08-09 1998-03-04 中国医学科学院药物研究所 一种制备平喘镇咳药物的新方法
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US6423719B1 (en) 1999-02-16 2002-07-23 Upsher-Smith Laboratories, Inc. Method for treating benign prostate hyperplasia
US6313131B1 (en) 1999-02-16 2001-11-06 Upsher-Smith Laboratories, Inc. Method of kidney treatment
CN101647776B (zh) * 2009-09-02 2011-04-20 吴光彦 多索茶碱小容量静脉注射液及其制备方法和质量控制方法
WO2011146031A1 (en) 2010-05-18 2011-11-24 Bilgic Mahmut Pharmaceutical composition comprising n- acetylcysteine and a xanthine
TR201104738A2 (tr) 2011-05-16 2012-12-21 Bi̇lgi̇ç Mahmut N-Asetilsistein içeren farmasötik kombinasyon.
CN102775405B (zh) * 2012-08-23 2014-03-12 天津梅花医药有限公司 一种高溶解度的多索茶碱化合物
CN109796454B (zh) * 2018-12-27 2020-10-23 北京鑫开元医药科技有限公司 多索茶碱杂质及其合成方法、用途、组合物及其制备方法
JP2022184639A (ja) 2021-06-01 2022-12-13 上村工業株式会社 銅エッチング液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1523273A (fr) * 1967-03-13 1968-05-03 Soc Ind Fab Antibiotiques Sifa Nouveaux dérivés de théophylline et procédé de préparation
FR6106M (it) * 1967-06-12 1968-06-10
US4085214A (en) * 1976-10-18 1978-04-18 Interx Research Corporation Stable pro-drug forms of theophylline

Also Published As

Publication number Publication date
US4187308A (en) 1980-02-05
IT1113122B (it) 1986-01-20
NL7807152A (nl) 1979-10-09
BE868556A (nl) 1978-10-16
DE2827497C2 (de) 1985-10-24
JPS5715088B2 (it) 1982-03-29
GB1582510A (en) 1981-01-07
FR2421614B1 (it) 1982-09-10
FR2421614A1 (fr) 1979-11-02
DE2827497A1 (de) 1979-10-11
JPS54138127A (en) 1979-10-26

Similar Documents

Publication Publication Date Title
AT369262B (de) Shampoozusammensetzung
IT7928464A0 (it) Composizione farmaceutica avente attivita' antitumorale.
NL7903029A (nl) 2'deoxy-5-(2-halogeenvinyl)-uridines.
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
DZ206A1 (fr) Dérivés de l'indante et médicament qui en contiennent.
IT7822019A0 (it) Composizione farmaceutica adattivita' antibroncospastica e antitosse.
IT1126406B (it) 1,2,4,5-tetra-alchil-4-arilpiperidine e relative formulazioni farmaceutiche
IT1193847B (it) Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline
FI792319A (fi) Guargum innehaollande farmaceutisk komposition
IT7920567A0 (it) Meccanismo d'interbloccaggio di formulazione d'indirizzo.
NL7903769A (nl) Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
NZ189881A (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and pharmaceutical compositions
BE880282A (fr) 4,1-benzoxazepines et 4,1-benzothiazepines
DK461579A (da) Farmeceutisk komposition indeholdende en aryltrifluorethanol
AR227139A1 (es) Composicion pesticida
LU81071A1 (fr) Vitrai 12
NL190706B (nl) Vlamonderdrukkende samenstellingen en voorwerpen daarmee bekleed.
FI790141A (fi) 2 6-dinitrobensenaminer
IT1122309B (it) Rele'elettromagnetico
NL190120C (nl) 2,3-dihydro-4h-1-benzopyran-4-on-0-carbamoyloximen alsmede farmaceutisch preparaat daarvan.
NL7900005A (nl) 11-alkanoyl-4"-desoxy-4"-isonitrilo-oleandomycine-deri- vaten.
BE883955A (fr) "limnimetre"
IT1194677B (it) Composizione farmaceutica ad attivita' antiflogistica,antipiretica e antalgica
IT1118828B (it) Composti e composizioni farmaceutiche ad azione mucolitica

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 112

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 112, 19920416; ISTITUTO BIOLOGICO CHEMIOTERAPICO A B C S.P.A.

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970329